We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > SK Capital

News List

SK Capital Completes Acquisition of BFS from Catalent Pharma Solutions contractpharma
April 01, 2021
SK Capital Partners LP, a private investment firm focused on the specialty materials, chemicals and pharmaceuticals sectors, has completed its previously announced acquisition of the Blow-Fill-Seal (BFS) Sterile Contract Development and Manufacturing ...
SK Capital to buy API business from Perrigo Company pharmaceutical-technology
August 15, 2017
Private investment company SK Capital has signed a new definitive agreement to purchase Perrigo Company’s active pharmaceutical ingredients (API) business, Perrigo API.Perrigo API develops and produces generic APIs and finished dose forms (FDF).
SK Capital Acquires Perrigo Company’s API Business americanpharmaceuticalreview
August 11, 2017
SK Capital has signed a definitive agreement to acquire Perrigo API business.This acquisition complements other companies SK owns and operates in the API and FDF value chain including Noramco, Tasmanian Alkaloids and Halo Pharmaceutical, all of which will